Chiro: Smart move. After taking numerous CBD products, I finally got the gummies with last order and frankly I love them. The citrus flavor is just enough to cover up the CBD taste, which I've grown to like over the last 3 years. We are hitting a critical time in acceptance. You know something is happening nationally when conservative 60 plus year olds are talking about it.
With Gottleib's resignation, it throws a small monkey wrench into things. But who says that will slow down the path toward a regulatory solution? It may not. And some have implied he didn't want to slog through changing the CBD regulation. That's so presumptuous. He lasted 2 years in the Trump administration and it was in his opinion, time to go. He will do very well in the private sector, I can assure you. In pharma. But the CBD train has left and is carry too much freight. Some things may slow it down (like regulatory uncertainty and day trader anxiety), but we have the San Diego bullet train with a very seasoned conductor (Dowling) and Engine Guy (Tomc), with lots of support from experienced hemp folk (Mona III) and now a dream person in the regulatory position (Duffy MacKay). The longs are a little frustrated with the 6 month consolidation (hoping it was 20 - I get it!). The day traders are frustrated because it has not been making big changes. At this point, the lack of uplist is related to the grayness of the CBD space and lack of legal financing. The lawsuit is BS and not holding it up. If that were the case, every time a company announced it might uplist, someone would spuriously sue them.
Longs just need to remain patient. Good news is coming on March 12. Day traders, let this thing run a little after the good news; don't take your freakin' 0.50 a share profit. I say that for selfish reasons, but let it run like a Tilray.
And Chiro, always good to hear from you. Keep on helping people with CBD, one patient at a time.
All the best to all.
MT
News 
Market Data 
Discover 
AI
